These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 27011900)
1. Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire. Suh JH; Saba JD Transl Cancer Res; 2015 Oct; 4(5):469-483. PubMed ID: 27011900 [TBL] [Abstract][Full Text] [Related]
2. S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer. Degagné E; Saba JD Clin Exp Gastroenterol; 2014; 7():205-14. PubMed ID: 25061328 [TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. Degagné E; Pandurangan A; Bandhuvula P; Kumar A; Eltanawy A; Zhang M; Yoshinaga Y; Nefedov M; de Jong PJ; Fong LG; Young SG; Bittman R; Ahmedi Y; Saba JD J Clin Invest; 2014 Dec; 124(12):5368-84. PubMed ID: 25347472 [TBL] [Abstract][Full Text] [Related]
4. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease. Sukocheva OA; Lukina E; McGowan E; Bishayee A Adv Protein Chem Struct Biol; 2020; 120():123-158. PubMed ID: 32085881 [TBL] [Abstract][Full Text] [Related]
5. Modulation of sphingosine-1-phosphate in inflammatory bowel disease. Peyrin-Biroulet L; Christopher R; Behan D; Lassen C Autoimmun Rev; 2017 May; 16(5):495-503. PubMed ID: 28279838 [TBL] [Abstract][Full Text] [Related]
6. Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase. Schwiebs A; Herrero San Juan M; Schmidt KG; Wiercinska E; Anlauf M; Ottenlinger F; Thomas D; Elwakeel E; Weigert A; Farin HF; Bonig H; Scholich K; Geisslinger G; Pfeilschifter JM; Radeke HH Oncogene; 2019 Jun; 38(24):4788-4803. PubMed ID: 30816345 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of phosphorylated sphingosine kinase 1 expression in colitis-associated cancer. Yuza K; Nagahashi M; Shimada Y; Nakano M; Tajima Y; Kameyama H; Nakajima M; Takabe K; Wakai T J Surg Res; 2018 Nov; 231():323-330. PubMed ID: 30278948 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. Nagahashi M; Hait NC; Maceyka M; Avni D; Takabe K; Milstien S; Spiegel S Adv Biol Regul; 2014 Jan; 54():112-20. PubMed ID: 24210073 [TBL] [Abstract][Full Text] [Related]
10. [The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases]. Szymaszkiewicz K; Szymaszkiewicz A; Fichna J Postepy Biochem; 2020 Mar; 66(1):42-48. PubMed ID: 33320478 [TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study. Suh JH; Degagné É; Gleghorn EE; Setty M; Rodriguez A; Park KT; Verstraete SG; Heyman MB; Patel AS; Irek M; Gildengorin GL; Hubbard NE; Borowsky AD; Saba JD Inflamm Bowel Dis; 2018 May; 24(6):1321-1334. PubMed ID: 29788359 [TBL] [Abstract][Full Text] [Related]
12. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Fantini MC; Guadagni I Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1. He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514 [TBL] [Abstract][Full Text] [Related]
15. Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management. Kitsou K; Kokkotis G; Rivera-Nieves J; Bamias G Drugs; 2024 Oct; 84(10):1179-1197. PubMed ID: 39322927 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease. Wollny T; Wątek M; Durnaś B; Niemirowicz K; Piktel E; Żendzian-Piotrowska M; Góźdź S; Bucki R Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362332 [TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate (S1P) signaling regulates the production of intestinal IgA and its potential role in the pathogenesis of canine inflammatory bowel disease. Nakazawa M; Maeda S; Yokoyama N; Nakagawa T; Yonezawa T; Ohno K; Matsuki N J Vet Med Sci; 2019 Sep; 81(9):1249-1258. PubMed ID: 31341112 [TBL] [Abstract][Full Text] [Related]
20. The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis. Al-Jarallah A; Oriowo M PLoS One; 2017; 12(5):e0170792. PubMed ID: 28493876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]